Y, Z., J, D., & X, S. (2023). Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond. Frontiers in immunology, 14, 1157537. https://doi.org/10.3389/fimmu.2023.1157537
Chicago Style (17th ed.) CitationY, Zhao, Du J, and Shen X. "Targeting Myeloid-derived Suppressor Cells in Tumor Immunotherapy: Current, Future and Beyond." Frontiers in Immunology 14 (2023): 1157537. https://doi.org/10.3389/fimmu.2023.1157537.
MLA (9th ed.) CitationY, Zhao, et al. "Targeting Myeloid-derived Suppressor Cells in Tumor Immunotherapy: Current, Future and Beyond." Frontiers in Immunology, vol. 14, 2023, p. 1157537, https://doi.org/10.3389/fimmu.2023.1157537.
Warning: These citations may not always be 100% accurate.